ANTIPODEAN PHARMACEUTICALS
Antipodean Pharmaceuticals is a creator of pharmaceuticals for antioxidant therapy, anti-aging, and rejuvenation. Mitochondria behind health and wellness.
ANTIPODEAN PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2002-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.antipodeanpharma.com
Total Employee:
1+
Status:
Active
Contact:
+64 9 303 2986
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro LetsEncrypt IPv6 Cloudflare Hosting Cloudflare CDN Cloudflare PHP PHP 7
Similar Organizations
AnthroTronix
AnthroTronix is an award-winning research and development (R&D) company.
Biomat Sciences
Biomat Sciences is a research and development life science business.
Cellular Research
A biotechnology research and development company
EIC Laboratories
EIC Laboratories is a research and development company.
Genetics Institute
Genetics Institute is a U.S.-based biotechnology research and development company.ย
Innovative Solutions Canada
Innovative Solutions Canada is a research and development procurement program.
Orphagen Pharmaceuticals
Orphagen Pharmaceuticals is a drug discovery company.
ShengNuo Biology
ShengNuo Biology is a polypeptide drug and product development company.
Swapsol
An environmental research & development company.
Transposagen Biopharmaceuticals
Transposagen Biopharmaceuticals provides animal models of human diseases for drug discovery and development.
Current Advisors List
Official Site Inspections
http://www.antipodeanpharma.com
- Host name: 104.21.96.1
- IP address: 104.21.96.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Antipodean Pharmaceuticals"
Antipodean Pharmaceuticals - Crunchbase Company Profile
Antipodean Pharmaceuticals is a research and development company. Antipodean Pharmaceuticals is a creator of pharmaceuticals for antioxidant therapy, anti-aging, and โฆSee details»
Antipodean Pharmaceuticals, Inc. (Antipodean Pharmaceuticals, Inc ...
Further information is available at . Antipodean Pharmaceuticals CONTACT: Eric Bizjak of Antipodean Pharmaceuticals, Inc., +1-415-692-0610,[email protected]; or โฆSee details»
Antipodean Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Antipodean Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 1 news, Drug:Mitoquinone mesylate ...See details»
ANTIPODEAN PHARMACEUTICALS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ANTIPODEAN PHARMACEUTICALS, INC. of San Francisco, CA. Get the latest business insights from Dun โฆSee details»
Antipodean Pharmaceuticals - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Antipodean Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Antipodean Pharmaceuticals - Craft
Antipodean Pharmaceuticals is a creator of pharmaceuticals for antioxidant therapy, anti-aging, and rejuvenation. One of its products is MitoQ, mitochondria-targeted CoQ10 antioxidant, that โฆSee details»
Antipodean Pharmaceuticals - Overview, News & Similar
View Antipodean Pharmaceuticals (www.antipodeanpharma.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as โฆSee details»
Antipodean Pharmaceuticals Inc - Company Profile and News
Company profile page for Antipodean Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Antipodean Pharmaceuticals, Inc - EverybodyWiki Bios & Wiki
Antipodean Pharmaceuticals is a creator of products for antioxidant therapy, anti-aging and rejuvenation. One of its product is MitoQ, a mitochondria-targeted CoQ10 antioxidant. In 2008, โฆSee details»
Antipodean - Products, Competitors, Financials, Employees, โฆ
Antipodean is a pharmaceutical company developing treatments for neurodegenerative diseases such as Parkinson's Disease and Friedreich's Ataxia that are associated with mitochondrial โฆSee details»
Antipodean Pharmaceuticals - Company Profile - Tracxn
Nov 27, 2024 Website: antipodeanpharma.com; Email ID: *****@antipodeanpharma.com; Phone Number: +1 ***** Key Metrics. Ranked. 321 st among 321 competitors. Similar Companies. โฆSee details»
Mitoquinone mesylate - Drug Targets, Indications, Patents - Synapse
Originator Organization. Antipodean (UK) Ltd. Active Organization. University of Connecticut Health Center Korea National University of Transportation. ... Eric Bizjak of Antipodean โฆSee details»
Antipodean Pharmaceuticals Inc. Establishes San Francisco
Apr 11, 2006 Further information is available from the website: www.antipodeanpharma.com Antipodean Pharmaceuticals, Inc. CONTACT: Jennifer Larson, +1-415-725-2017, or +1-415 โฆSee details»
Antipodean Pharmaceuticals Announces FDA Acceptance Of IND โฆ
Jun 5, 2008 Antipodean Pharmaceuticals, Inc. announced recently that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's Investigational New Drug (IND) โฆSee details»
Antipodean Pharmaceuticals, Inc. Announces FDA Acceptance of
Antipodean Pharmaceuticals, Inc. Announces FDA Acceptance of ... - BioSpaceSee details»
Antipodean Pharmaceuticals, Inc. Completes Phase 2 Trial
Nov 27, 2006 Further information is available at www.antipodeanpharma.com. Antipodean Pharmaceuticals CONTACT: Eric Bizjak of Antipodean Pharmaceuticals, Inc., +1-415-692 โฆSee details»
Antipodean Pharmaceuticals Announces Completion of Phase 2 โฆ
SAN FRANCISCO, April 10 /PRNewswire/ -- Antipodean Pharmaceuticals, Inc. announced today that it has completed its Phase 2 study of its lead compound, MitoQ(R) (mitoquinone) in liver โฆSee details»
Antipodean Pharmaceuticals, Inc. Announces FDA Acceptance of
SAN FRANCISCO, June 3 /PRNewswire/ -- Antipodean Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the Companyโs โฆSee details»
Antipodean Pharmaceuticals, Inc. Announces Completion of
SAN FRANCISCO, April 10 /PRNewswire/ -- Antipodean Pharmaceuticals, Inc. announced today that it has completed its Phase 2 study of its lead compound, MitoQ(R) (mitoquinone) in liver โฆSee details»
Antipodean Pharmaceuticals, Inc. Initiates Phase 2 Trial In
Antipodean Pharmaceuticals, Inc. Initiates Phase 2 Trial In ... - BioSpaceSee details»